<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37600819</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Classifying flow cytometry data using Bayesian analysis helps to distinguish ALS patients from healthy controls.</ArticleTitle><Pagination><StartPage>1198860</StartPage><MedlinePgn>1198860</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1198860</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1198860</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Given its wide availability and cost-effectiveness, multidimensional flow cytometry (mFC) became a core method in the field of immunology allowing for the analysis of a broad range of individual cells providing insights into cell subset composition, cellular behavior, and cell-to-cell interactions. Formerly, the analysis of mFC data solely relied on manual gating strategies. With the advent of novel computational approaches, (semi-)automated gating strategies and analysis tools complemented manual approaches.</AbstractText><AbstractText Label="METHODS">Using Bayesian network analysis, we developed a mathematical model for the dependencies of different obtained mFC markers. The algorithm creates a Bayesian network that is a HC tree when including raw, ungated mFC data of a randomly selected healthy control cohort (HC). The HC tree is used to classify whether the observed marker distribution (either patients with amyotrophic lateral sclerosis (ALS) or HC) is predicted. The relative number of cells where the probability q is equal to zero is calculated reflecting the similarity in the marker distribution between a randomly chosen mFC file (ALS or HC) and the HC tree.</AbstractText><AbstractText Label="RESULTS">Including peripheral blood mFC data from 68 ALS and 35 HC, the algorithm could correctly identify 64/68 ALS cases. Tuning of parameters revealed that the combination of 7 markers, 200 bins, and 20 patients achieved the highest AUC on a significance level of p &lt; 0.0001. The markers CD4 and CD38 showed the highest zero probability. We successfully validated our approach by including a second, independent ALS and HC cohort (55 ALS and 30 HC). In this case, all ALS were correctly identified and side scatter and CD20 yielded the highest zero probability. Finally, both datasets were analyzed by the commercially available algorithm 'Citrus', which indicated superior ability of Bayesian network analysis when including raw, ungated mFC data.</AbstractText><AbstractText Label="DISCUSSION">Bayesian network analysis might present a novel approach for classifying mFC data, which does not rely on reduction techniques, thus, allowing to retain information on the entire dataset. Future studies will have to assess the performance when discriminating clinically relevant differential diagnoses to evaluate the complementary diagnostic benefit of Bayesian network analysis to the clinical routine workup.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 R&#xe4;uber, Nelke, Schroeter, Barman, Pawlitzki, Ingwersen, Akg&#xfc;n, G&#xfc;nther, Garza, Marggraf, Dunay, Schreiber, Vielhaber, Ziemssen, Melzer, Ruck, Meuth and Herty.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>R&#xe4;uber</LastName><ForeName>Saskia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical Faculty, Heinrich Heine University of D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nelke</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical Faculty, Heinrich Heine University of D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schroeter</LastName><ForeName>Christina B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical Faculty, Heinrich Heine University of D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barman</LastName><ForeName>Sumanta</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical Faculty, Heinrich Heine University of D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pawlitzki</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical Faculty, Heinrich Heine University of D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ingwersen</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical Faculty, Heinrich Heine University of D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akg&#xfc;n</LastName><ForeName>Katja</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nther</LastName><ForeName>Rene</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garza</LastName><ForeName>Alejandra P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Institute of Inflammation and Neurodegeneration, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marggraf</LastName><ForeName>Michaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dunay</LastName><ForeName>Ildiko Rita</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>Institute of Inflammation and Neurodegeneration, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schreiber</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Otto von Guericke University, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vielhaber</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Otto von Guericke University, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziemssen</LastName><ForeName>Tjalf</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melzer</LastName><ForeName>Nico</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical Faculty, Heinrich Heine University of D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruck</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical Faculty, Heinrich Heine University of D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meuth</LastName><ForeName>Sven G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical Faculty, Heinrich Heine University of D&#xfc;sseldorf, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herty</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Mathematics, Institute of Geometry and Applied Mathematics, RWTH Aachen University, Aachen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002450" MajorTopicYN="N">Cell Communication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Bayesian analysis</Keyword><Keyword MajorTopicYN="N">flow cytometry</Keyword><Keyword MajorTopicYN="N">immune system</Keyword><Keyword MajorTopicYN="N">mathematical modeling</Keyword></KeywordList><CoiStatement>SR received travel reimbursements from Merck Healthcare Germany GmbH and Alexion Pharmaceuticals. She served on a scientific advisory board from Merck Healthcare Germany GmbH and her research was supported by Novartis and the Stiftung zur F&#xf6;rderung junger Neurowissenschaftler. CS received travel reimbursements from Merck Healthcare Germany GmbH and Alexion Pharmaceuticals. She served on a scientific advisory board from Merck Healthcare Germany GmbH. MP received honoraria for lecturing from Argenx, Biogen, Bayer, Novartis, Hexal, Sanofi and Merck. He received research funding from Biogen. KA received personal compensation for consulting services and speaker honoraria from Roche, Novartis, Merck, Sanofi, Teva, BMS, Biogen, and Celgene. SM received honoraria for lecturing and travel expenses for attending meetings from Almirall, Amicus Therapeutics Germany, Bayer HealthCare, Biogen, Celgene, Diamed, Genzyme, MedDay Pharmaceuticals, Merck Serono, Novartis, Novo Nordisk, ONO Pharma, Roche, Sanofi-Aventis, Chugai Pharma, QuintilesIMS, and Teva. His research is funded by the German Ministry for Education and Research BMBF, Bundesinstitut f&#xfc;r Risikobewertung BfR, Deutsche Forschungsgemeinschaft DFG, Else Kr&#xf6;ner Fresenius Foundation, Gemeinsamer Bundesausschuss G-BA, German Academic Exchange Service, Hertie Foundation, Interdisciplinary Center for Clinical Studies IZKF Muenster, German Foundation Neurology and by Alexion, Almirall, Amicus Therapeutics Germany, Biogen, Diamed, Fresenius Medical Care, Genzyme, HERZ Burgdorf, Merck Serono, Novartis, ONO Pharma, Roche, and Teva. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>4</Hour><Minute>50</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37600819</ArticleId><ArticleId IdType="pmc">PMC10434536</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1198860</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aghaeepour N, Finak G, FlowCAP Consortium. DREAM Consortium. Hoos H, Mosmann TR, et al. . Critical assessment of automated flow cytometry data analysis techniques. Nat Methods (2013) 10:228&#x2013;38. doi:&#xa0;10.1038/nmeth.2365</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2365</ArticleId><ArticleId IdType="pmc">PMC3906045</ArticleId><ArticleId IdType="pubmed">23396282</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruggner RV, Bodenmiller B, Dill DL, Tibshirani RJ, Nolan GP. Automated identification of stratifying signatures in cellular subpopulations. Proc Natl Acad Sci U S A (2014) 111:E2770&#x2013;7. doi:&#xa0;10.1073/pnas.1408792111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1408792111</ArticleId><ArticleId IdType="pmc">PMC4084463</ArticleId><ArticleId IdType="pubmed">24979804</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z, Bhattacharya S, Butte AJ. Application of machine learning for cytometry data. Front Immunol (2021) 12:787574. doi:&#xa0;10.3389/fimmu.2021.787574</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.787574</ArticleId><ArticleId IdType="pmc">PMC8761933</ArticleId><ArticleId IdType="pubmed">35046945</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M, G&#xfc;nther R, Akg&#xfc;n K, Hermann A, Ziemssen T. Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis. Sci Rep (2020) 10:5941. doi:&#xa0;10.1038/s41598-020-62756-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62756-8</ArticleId><ArticleId IdType="pmc">PMC7125229</ArticleId><ArticleId IdType="pubmed">32246039</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza AP, Morton L, P&#xe1;llinger &#xc9;, Buz&#xe1;s EI, Schreiber S, Schott BH, et al. . Initial and ongoing tobacco smoking elicits vascular damage and distinct inflammatory response linked to neurodegeneration. Brain Behav Immun Health (2023) 28:100597. doi:&#xa0;10.1016/j.bbih.2023.100597</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2023.100597</ArticleId><ArticleId IdType="pmc">PMC9931921</ArticleId><ArticleId IdType="pubmed">36817509</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan H, Darwiche A. Reasoning about Bayesian network classifiers. arXiv preprint arXiv:12122470 (2012) 107. doi:&#xa0;10.48550/arXiv.1212.2470</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1212.2470</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow C, Liu C. Approximating discrete probability distributions with dependence trees. IEEE Trans Inform Theory (1968) 14:462&#x2013;7. doi:&#xa0;10.1109/TIT.1968.1054142</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TIT.1968.1054142</ArticleId></ArticleIdList></Reference><Reference><Citation>
Koski T. (2010). Lecturs on Statistical Learning Theory for Chow-Liu Trees, in: The 32nd Finnish Summer School on Probability Theory, (Stockholm: KTH Matematik; ). Available at: https://people.kth.se/~tjtkoski/chowliulect.pdf
</Citation></Reference><Reference><Citation>Bolt JH, Renooij S. Structure-Based Categorisation of Bayesian Network Parameters.. In: Antonucci, A., Cholvy, L., Papini, O. (eds) Symbolic and Quantitative Approaches to Reasoning with Uncertainty. ECSQARU. Lecture Notes in Computer Science. Springer, Cham; (2017) 10369 p. 83&#x2013;92. doi:&#xa0;10.1007/978-3-319-61581-3_8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-61581-3_8</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafond M, Noutahi E, El-Mabrouk N. Efficient non-binary gene tree resolution with weighted reconciliation cost. In 27th Annual Symposium on Combinatorial Pattern Matching. Schloss Dagstuhl-Leibniz-Zentrum fuer Informatik. (2016)</Citation></Reference><Reference><Citation>Scanagatta M, Corani G, De Campos CP, Zaffalon M. Learning treewidth-bounded Bayesian networks with thousands of variables. Adv Neural Inf Process Syst (2016) 29 1470&#x2013;7..</Citation></Reference><Reference><Citation>Wallace CS, Patrick JD. Coding decision trees. Mach Learn (1993) 11:7&#x2013;22. doi:&#xa0;10.1023/A:1022646101185</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1022646101185</ArticleId></ArticleIdList></Reference><Reference><Citation>
Inkscape Project . Inkscape (2020). Available at: https://inkscape.org.</Citation></Reference><Reference><Citation>Gross CC, Schulte-Mecklenbeck A, Madireddy L, Pawlitzki M, Strippel C, R&#xe4;uber S, et al. . Classification of neurological diseases using multi-dimensional CSF analysis. Brain (2021) 144:2625&#x2013;34. doi:&#xa0;10.1093/brain/awab147</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab147</ArticleId><ArticleId IdType="pmc">PMC8557345</ArticleId><ArticleId IdType="pubmed">33848319</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xe4;uber S, Heming M, Repple J, Ruland T, Kuelby R, Schulte-Mecklenbeck A, et al. . Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses. Mol Psychiatry (2021) 26:7661&#x2013;70. doi:&#xa0;10.1038/s41380-021-01244-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01244-5</ArticleId><ArticleId IdType="pmc">PMC8873003</ArticleId><ArticleId IdType="pubmed">34363013</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolfes L, Schulte-Mecklenbeck A, Schreiber S, Vielhaber S, Herty M, Marten A, et al. . Amyotrophic lateral sclerosis patients show increased peripheral and intrathecal T-cell activation. Brain Commun (2021) 3:fcab157. doi:&#xa0;10.1093/braincomms/fcab157</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab157</ArticleId><ArticleId IdType="pmc">PMC8363480</ArticleId><ArticleId IdType="pubmed">34405141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung M, Campbell JJ, Whitby L, Thomas RJ, Braybrook J, Petzing J. Current trends in flow cytometry automated data analysis software. Cytometry A (2021) 99:1007&#x2013;21. doi:&#xa0;10.1002/cyto.a.24320</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.24320</ArticleId><ArticleId IdType="pubmed">33606354</ArticleId></ArticleIdList></Reference><Reference><Citation>Velliangiri S, Alagumuthukrishnan S, Thankumar joseph SI. A review of dimensionality reduction techniques for efficient computation. Proc Comput Sci (2019) 165:104&#x2013;11. doi:&#xa0;10.1016/j.procs.2020.01.079</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.procs.2020.01.079</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Schoot R, Depaoli S, King R, Kramer B, M&#xe4;rtens K, Tadesse MG, et al. . Bayesian statistics and modelling. Nat Rev Methods Primers (2021) 1:1. doi:&#xa0;10.1038/s43586-020-00001-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43586-020-00001-2</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>